Because Aβ and Aβ-plaques are believed central to the pathogenesis of AD, it is postulated that TREM2 mutations reduce TREM2 function and increase dementia risk by hampering the anti-amyloidogenic activity of microglia. Here, TREM2 is linked to Alzheimer disease.